Proficiency testing within Eurotransplant.

Eurotransplant histocompatibility testing patient-based cases proficiency test solid organ transplantation

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2024
Historique:
received: 19 06 2024
accepted: 06 09 2024
medline: 8 10 2024
pubmed: 8 10 2024
entrez: 8 10 2024
Statut: epublish

Résumé

Eurotransplant is responsible for the international allocation of organs between eight countries in Europe. All HLA laboratories affiliated to Eurotransplant must be EFI or ASHI-accredited and must participate in the Eurotransplant external proficiency testing (EPT) program, organized by the Eurotransplant Reference Laboratory (ETRL). EPT within Eurotransplant has a long tradition, starting in 1978. The current EPT program consists of the following schemes: HLA typing including serology, CDC crossmatching, HLA-specific antibody detection, and identification. Participants enter the results of laboratory tests using a web-based application. Assessed results are visible on the website. An additional component called "patient-based cases" runs since 2016. Results are summarized and published on the EPT website. Furthermore, these results are discussed during the annual extramural tissue typers meeting, which is organized by the ETRL. Thanks to this EPT program, the performance of all HLA laboratories affiliated to Eurotransplant can be monitored and corrected, if necessary. Because all affiliated laboratories are assessed in the same EPT program, where these laboratories show to be consistent in most of their results, Eurotransplant EPT has proven to be an efficient tool to create a more uniform level of quality of histocompatibility testing within Eurotransplant.

Identifiants

pubmed: 39376741
doi: 10.3389/fgene.2024.1451748
pii: 1451748
pmc: PMC11456461
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1451748

Informations de copyright

Copyright © 2024 Zoet, Heidt, van der Linden-van Oevelen, Haasnoot and Claas.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Yvonne M Zoet (YM)

Immunology-ETRL, Leiden University Medical Center (LUMC), Leiden, Netherlands.

Sebastiaan Heidt (S)

Immunology-ETRL, Leiden University Medical Center (LUMC), Leiden, Netherlands.

Marissa J H van der Linden-van Oevelen (MJH)

Immunology-ETRL, Leiden University Medical Center (LUMC), Leiden, Netherlands.

Geert W Haasnoot (GW)

Immunology-ETRL, Leiden University Medical Center (LUMC), Leiden, Netherlands.

Frans H J Claas (FHJ)

Eurotransplant, Leiden, Netherlands.

Classifications MeSH